The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization.

Rafael Bayarri-Olmos1 Anne Rosbjerg2,3 Laust Bruun Johnsen4 Charlotte Helgstrand4 Theresa Bak-Thomsen4 Peter Garred1 Mikkel-Ole Skjoedt2,5
Affiliations 5 institutions
  1. Laboratory of Molecular Medicine, Department of Clinical Immunology, University Hospital of Copenhagen, Copenhagen, Denmark.
  2. Laboratory of Molecular Medicine, Department of Clinical Immunology, University Hospital of Copenhagen, Copenhagen, Denmark
  3. Institute of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  4. Novo Nordisk A/S, Måløv, Denmark.
  5. Institute of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. Electronic address: [email protected].

Abstract

Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 from humans to animals has been reported for many domesticated species, including farmed minks. The identification of novel spike gene mutations appearing in minks has raised major concerns about potential immune evasion and challenges for the global vaccine strategy. One genetic variant, known as "cluster five," arose among farmed minks in Denmark and resulted in a complete shutdown of the world's largest mink production. However, the functional properties of this new variant are not established. Here we present functional data on the cluster-five variant, which contains a mutation resulting in a Y453F residue change in the receptor-binding domain (RBD) of the spike protein. Using an ELISA-based angiotensin-converting enzyme-2/RBD inhibition assay, we show that the Y453F variant does not decrease established humoral immunity from previously infected individuals or affect the neutralizing antibody response in a vaccine mouse model based on the original Wuhan strain RBD or spike as antigens. However, biolayer interferometry analysis demonstrates that it binds the human angiotensin-converting enzyme-2 receptor with a 4-fold higher affinity than the original strain, suggesting an enhanced transmission capacity and a possible challenge for viral control. These results also indicate that the rise in the frequency of the cluster-five variant in mink farms might be a result of the fitness advantage conferred by the receptor adaptation rather than evading immune responses.

Supporting text Virus Host Location
ACE-2 1 antibodies 18 immunology 2 mutant 1 RBD 13 receptor interaction 1 receptor structure–function 1 RNA virus 2 SARS-CoV-2 550 Virology 11 Pandemics 108 Amino Acid Substitution 81 Angiotensin-Converting Enzyme 2 177 Animals 1948 Antibodies, Neutralizing 80 Antibodies, Viral 212 Convalescence 1 COVID-19 425 Denmark 7 Gene Expression 10 HEK293 Cells 61 Host-Pathogen Interactions 55 Humans 1440 Immune Sera 9

Evidence records

3 total
Zoonotic Surveillance
1 records · 1 evidence types
Evidence type
1 records
OVE4613
Key finding

Sera from previously infected individuals maintained neutralizing activity against the SARS-CoV-2 Y453F mink variant, indicating no reduction in established humoral immunity.

Virus
Host
Location
Not specified
Supporting text

We show that the Y453F variant does not decrease established humoral immunity from previously infected individuals.

Method
ELISA-based ACE2/RBD inhibition assay | neutralization assay
Sample type
sera
Functional Mechanism
2 records · 2 evidence types
Evidence type
1 records
OVE4612
Key finding

The SARS-CoV-2 Y453F mink variant binds the human ACE2 receptor with four-fold higher affinity compared to the original strain.

Virus
Host
Location
Not specified
Supporting text

Biolayer interferometry analysis demonstrates that it binds the human angiotensin-converting enzyme-2 receptor with a 4-fold higher affinity than the original strain.

Method
biolayer interferometry analysis
Receptors
human angiotensin-converting enzyme-2 receptor | ACE-2
Evidence type
1 records
OVE4611
Key finding

The SARS-CoV-2 Y453F mink variant shows receptor adaptation, with its spike protein binding the human ACE‑2 receptor at higher affinity, indicating a potential transmission fitness advantage.

Virus
Host
Not specified
Location
Not specified
Supporting text

The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization. Biolayer interferometry analysis demonstrates that it binds the human angiotensin-converting enzyme-2 receptor with a 4-fold higher affinity than the original strain, suggesting an enhanced transmission capacity and a possible challenge for viral control.

Genes or proteins
spike protein | receptor-binding domain (RBD)
Receptors
human ACE-2 receptor | angiotensin-converting enzyme-2 receptor
Mutations
Y453F
Mechanism types
receptor binding | host entry | transmission fitness